Exelixis (EXEL) Stock Price Today & Analysis
EXEL
Valuation
Market cap$11.79B
Price-to-sales ratio5.32
Price-to-book value5.64
Price-earnings ratio18.00
Return on Equity32.00%
Return on Sales0.38%
Return on Assets0.24%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$2.46
Income Statement
Average volume2,475,673
EBITDA$927.60M
1 year high (52w)$49.62
1 year low (52w)$31.90
Dividend
Dividend yield0.00%
Solvency
Debt-to-equity ratioN/A
About Exelixis
Exelixis, Inc., a biotechnology company strong focus on discovering, developing, and commercializing innovative therapies for treating cancer, the company has made significant strides in advancing its pipeline of targeted oncology treatments. Exelixis is renowned for its flagship drug, Cabometyx (cabozantinib), which has gained approvals for various cancer indications, demonstrating the company's dedication to improving patients' lives. Through strategic collaborations, cutting-edge research, and a commitment to scientific excellence, Exelixis continues to be at the forefront of delivering breakthrough therapies in the fight against cancer.
FAQ
You can easily purchase Exelixis (EXEL) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'EXEL' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Exelixis with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
